EU Notices Inequalities In Coronavirus Vaccines
There is an inequality in the coronavirus vaccines in the EU. As ABC News notes, millions of people vaccinated against COVID-19 may be banned from entering some European countries.
In particular, the AstraZeneca vaccine produced in Europe has been approved by the European Medicines Agency. At the same time, a number of countries do not recognise the same drug produced in India. According to the European regulator, the pharmaceutical company allegedly failed to complete the necessary paperwork at the Indian plant, including papers on quality control standards.
According to some experts, such a decision by the EU is discriminatory. It is noted that such a situation will adversely affect the ability of vaccinated citizens to travel, which will hit the fragile economy. Moreover, it will undermine people’s trust in vaccines, as the quality of some drugs will then be questionable.
A resident of Nigeria who received the Indian version of AstraZeneca noted that the drug he received was approved by the World Health Organization (WHO) for use in emergencies. In his view, the EU decision gives room for conspiracy theories that the vaccines that people in Africa receive are not as good as those that Western countries make for themselves.
The EU list of officially approved vaccines also includes Pfizer, Moderna and Johnson & Johnson. Many other vaccines used in developing countries are not on the list, including those made in China and Russia. However, some states may grant free passage to people who have received other vaccines.